Wells Fargo
FOLD

Wells Fargo’s Amicus Therapeutics FOLD Stock Holding History

Wells Fargo’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-59,700
Closed -$167K – 6454
2018
Q2 		$167K Buy
+59,700
New +$902K ﹤0.01% 5131

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Wells Fargo's FOLD Position: Q2 2026 in Review

Wells Fargo sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 111,070 shares — an estimated $1.61M sold.

Wells Fargo first reported a position in FOLD in Q2 2013 and held it in 47 quarters. The position peaked at $42.5M in Q1 2018. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Wells Fargo reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 111,070 Amicus Therapeutics shares in Q2 2026, an estimated $1.61M.
  • Wells Fargo first reported a position in Amicus Therapeutics in Q2 2013 and held it in 47 quarters.
  • Wells Fargo's Amicus Therapeutics position peaked at $42.5M in Q1 2018.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.